CM Management, LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 107 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
CM Management, LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$553
-51.6%
250,000
-44.4%
0.54%
-60.3%
Q1 2023$1,143
+77.2%
450,000
+30.4%
1.36%
+76.2%
Q4 2022$645
-99.9%
345,000
-13.8%
0.77%
-32.9%
Q3 2022$1,028,000
+52.1%
400,000
+14.3%
1.15%
+59.5%
Q2 2022$676,000
-35.0%
350,0000.0%0.72%
-17.6%
Q1 2022$1,040,000
-22.8%
350,000
+16.7%
0.87%
-14.2%
Q4 2021$1,347,000
+38.6%
300,000
+50.0%
1.02%
+40.4%
Q3 2021$972,000
-18.6%
200,000
+14.3%
0.72%
-16.0%
Q2 2021$1,194,000
+12.7%
175,000
+16.7%
0.86%
+9.7%
Q1 2021$1,059,000
+383.6%
150,000
+328.6%
0.79%
+287.7%
Q4 2020$219,00035,0000.20%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders